Centre halts HPV vaccine project

April 07, 2010 11:35 pm | Updated November 28, 2021 08:49 pm IST - NEW DELHI:

In the wake of reports of violation of ethical guidelines and exploitation during the “clinical trials” of HPV (human papilloma virus) vaccine, meant to prevent cervical cancer among women, the Centre on Wednesday advised the State governments to suspend the vaccine programme until the issue is settled.

Director-General of the Indian Council of Medical Research (ICMR) V.M. Katoch told The Hindu that he had asked the Health and Family Welfare Ministry, the State governments and the people not to go ahead with the programme. “There can be no compromise, if ethical issues have been violated by any non-governmental organisation or pharmaceutical company. The government is all for the people, and genuine issues have to be addressed.”

“I am not prematurely judging that the NGO is at fault, but if there are allegations, they need to be investigated, and concrete evidence has to be brought to our notice. But, until this happens, the programme needs to be suspended,” he said.

Communist Party of India (Marxist) MP Brinda Karat said it was important to know what would happen to those who were already vaccinated.

Explaining that the ICMR was only “technical facilitator” of the HPV vaccine project, Dr. Katoch said a memorandum was signed with PATH-International in February 2007 for a project allotted to it by the Bill and Melinda Gates Foundation for assessing the feasibility of introducing HPV vaccine in India. Pharmaceutical companies Merck and GSK were to provide the vaccine and the ICMR helped in protocol preparation and drawing up ethical guidelines.

Initially, the NGO conducted a survey on the social acceptability of the project with the help of a questionnaire among the socially disadvantaged groups, as cervical cancer occured more among the women from the disadvantaged sections with less health facilities and low-capacity for buying expensive drugs. By the time the trial ended, the Drugs-Controller of India gave approval for marketing the two vaccines.

Pointing out that the trial started after approval from the State Advisory Committees and the ethical committees of the Andhra Pradesh and Gujarat governments and the National Technical Advisory Group as per the agreement with the NGOs, Dr. Katoch said: “Everything was going fine until we received complaints of violation of guidelines and exploitation of people from civil society groups some months ago following the death of four girls, who were administered this vaccine.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.